I'm an IMC qualified contributor who's followed financial markets for 5 years and has worked professionally in primary investment research for over 2 years. I'm a generalist who enjoys researching businesses from a buttom's up angle with a deep interest in smaller under covered companies where there is greater opportunity for mis-pricing and finding asymmetric opportunities where the downside is limited.Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies me ...

MIAMI, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Defiance ETFs, a leader in thematic and leveraged exchange-traded funds, today announced the launch of the Defiance Daily Target 2X Long OSCR ETF (Ticker: OSCX). This fund provides investors with amplified 2X daily exposure to the performance of Oscar Health, Inc. – Class A (NYSE: OSCR), enabling retail investors to participate in the potential growth of an innovator in the healthcare sector without the need for a margin account. OSCX seeks to deliver daily investme ...

Oscar Health Inc OSCR just became one of Wall Street's buzziest policy trades. With ACA (Affordable Care Act) subsidy chatter swirling ahead of a possible government shutdown, the tech-driven insurer is drawing Hims & Hers Health Inc HIMS style moonshot comparisons — and short sellers may be sitting on a powder keg.Track OSCR stock here.With a short interest around 25% and a relatively thin float, Oscar Health has all the hallmarks of a HIMS-style setup—where headline catalysts can trigger rapid, outsized m ...

交易策略 - 通过现金担保看跌期权策略 可以利用奥斯卡健康股票的高波动性 以折价潜在买入股票[1] - 卖出执行价17美元 10月17日到期的看跌期权 可获得约110美元权利金[3] - 盈亏平衡点为15.90美元 较周三收盘价有10.5%折让[4] - 若股价保持在17美元以上 期权到期作废可获得6.92%的资本回报率 年化约84%[4] 公司评级表现 - 综合评级50分（满分99） 每股收益评级27分 相对强度评级73分[7] - 在行业组别中排名第43位[7] - 相对强度评级从76提升至84 显示价格表现改善[9] - 相对强度评级进一步跃升至92分 展现市场领导地位[12] 风险特征 - 最大亏损场景为股价归零 可能损失1590美元[5] - 该交易已避开财报风险 因公司第二季度业绩已公布[6] - 期权交易存在风险 投资者可能损失全部投资[7] 交易辅助策略 - 被行权后可通过卖出备兑看涨期权产生额外收益[6] - 该策略适合愿意持有该股票的投资者 可降低持股成本[6]

股价表现与估值 - 自强烈买入评级以来 Oscar Health股价上涨21% 显著超越标普500指数4%的涨幅 [1] - 公司估值倍数仅为约0.45倍营收 远低于同行3.19倍的平均水平 [1] - 当前估值水平仍显示公司存在可观上行空间 [1] 投资策略框架 - 投资聚焦于具备2-3倍上行潜力的不对称机会 通过市场非效率性和逆向洞察实现长期复利最大化 [1] - 采用4-5年投资周期以规避短期波动 强调资本保全与智能资产配置 [1] - 投资组合构建采用核心仓位(50-70%)、成长型押注(20-40%)和投机性配置(5-10%)的三层结构 [1] 公司分析维度 - 领导力与管理层需具备业务规模化经验 注重资本配置效率及内部人持股 alignment [1] - 市场竞争地位取决于技术护城河、先发优势及高增长行业的渗透能力 [1] - 财务健康度评估强调可持续营收增长、现金流效率及避免过度股权稀释 [1] - 估值分析采用营收倍数对标同行及DCF模型 结合机构持仓和市场情绪研判 [1]

Since my strong buy rating , Oscar Health (NYSE: OSCR ), is up 21%, well ahead of the S&P 500’s 4%. With a valuation multiple of just ~0.45x revenues versus peers at 3.19x, Oscar still offers considerable upside. TheHi, I'm Yiannis. Spotting winners before they break out is what I do best.Experience: Previously worked at Deloitte and KPMG in external/internal auditing and consulting. Education: Chartered Certified Accountant, Fellow Member of ACCA Global, with BSc and MSc degrees from U.K. business schools. ...

If you want full access to all our reports, data and investing ideas, join The Aerospace Forum , the #1 aerospace, defense and airline investment research service on Seeking Alpha, with access to evoX Data Analytics, our in-house developed data analytics platform.Babcock International Group ( OTCPK:BCKIF , OTCPK:BCKIY ) has gained 5.8% since my last report, performing more in line with the stock market. As a European defense contractor, I believe that the company can capitalize on Europe’sDhierin runs the i ...

Healthcare tech firm Oscar Health Inc. OSCR priced its offering of $355 million of 2.25% convertible senior subordinated notes due 2030 in a private offering.The company increased its offering size from the previously announced offering size of $350 million.Oscar estimates that the net proceeds from the offering will be approximately $342.5 million (or roughly $395.8 million if the initial purchasers fully exercise their option to purchase additional notes).Oscar intends to use net proceeds from the offerin ...

融资活动 - Oscar Health完成3.55亿美元可转换优先次级票据私募发行 较原计划3.5亿美元增加500万美元 [1] - 票据年利率为2.25% 2030年到期 [1] - 交易预计于2025年9月18日完成 附13天额外认购期权 [1]

Oscar Health Inc. OSCR shares are trending on Tuesday.Check out the current price of OSCR stock here. Shares on DipThe healthcare technology company’s shares dropped 3.63% in after-hours trading, falling to $18.05 from $18.73 at the close of Monday’s regular session. Oscar Health also revealed plans to offer $350 million in convertible senior subordinated notes.Convertible Notes Details Drive Market ReactionThe New York-based company intends to issue convertible notes due in 2030 through a private placement ...